Clinical studies have demonstrated its effectiveness in not only reducing body weight but also improving several health markers associated with obesity, including blood sugar levels and cardiovascular risk factors
This article provides a summary of the weight reduction effectiveness, glycemic control, and safety of semaglutide (up to a 2.4-mg dose) and tirzepatide (up to a 15-mg dose), with a focus on the Semaglutide Treatment Effect in People with Obesity (STEP) 2, SURPASS-1, and SURPASS-2 trials, which involved patients with type 2 diabetes mellitus
[DOI] [PubMed] [Google Scholar] 61.Herath RP, et al
One miscalculation cascades into another
It comes as a pre-filled pen, it lowers blood sugar, and because it slows the stomach and reduces appetite, many people also lose weight while taking it
And if you become pregnant unexpectedly, your care team can guide you through the next steps and adjust your treatment accordingly